Autoimmune Diseases and Risk of Non‐Hodgkin Lymphoma: A Mendelian Randomisation Study
Cancer Medicine · 2024
DOI: 10.1002/cam4.70327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Xiaoting Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Autoimmune Diseases, Lymphoma, Non-Hodgkin, Genetic Predisposition to Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background
Non‐Hodgkin lymphoma (NHL) is one of the most common haematologic malignancies in the world. Despite substantial efforts to identify causes and risk factors for NHL, its aetiology is largely unclear. Autoimmune diseases have long been considered potential risk factors for NHL. We carried out Mendelian randomisation (MR) analyses to examine whether genetically predicted susceptibility to ten autoimmune diseases (Behçet's disease, coeliac disease, dermatitis herpetiformis, lupus, psoriasis, rheumatoid arthritis, sarcoidosis, Sjögren's syndrome, systemic sclerosis, and type 1 diabetes) is associated with risk of NHL.
Methods
Two‐sample MR was performed using publicly available summary statistics from cohorts of European ancestry. For NHL and four NHL subtypes, we used data from UK Biobank, Kaiser Permanente cohorts, and FinnGen studies.
Results
Negative associations between type 1 diabetes and sarcoidosis and the risk of NHL were observed (odds ratio [OR] 0.95, 95% confidence interval [CI]: 0.92–0.98, p = 5 × 10 −3 , and OR 0.92, 95% CI: 0.85–0.99, p = 2.8 × 10 −2 , respectively). These findings were supported by the sensitivity analyses accounting for potential pleiotropy and weak instrument bias. No significant associations were found between the other eight autoimmune diseases and NHL risk.
Conclusion
These findings suggest that genetically predicted susceptibility to type 1 diabetes, and to some extent sarcoidosis, might reduce the risk of NHL. However, future studies with different datasets, approaches, and populations are warranted to further examine the potential associations between these autoimmune diseases and the risk of NHL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut, USA.
- Yale Center for Perinatal, Pediatric, and Environmental Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- Department of Chronic Diseases Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
- Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway.
ORCID-Profile: Xiaoting Shi, Joshua D Wallach, Xiaomei Ma, Tormod Rogne
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Shi, X., Wallach, J. D., Ma, X., & Rogne, T. (2024). Autoimmune Diseases and Risk of Non‐Hodgkin Lymphoma: A Mendelian Randomisation Study. Cancer Medicine. https://doi.org/10.1002/cam4.70327
Vancouver
Shi X, Wallach JD, Ma X, Rogne T. Autoimmune Diseases and Risk of Non‐Hodgkin Lymphoma: A Mendelian Randomisation Study. Cancer Medicine. 2024. doi:10.1002/cam4.70327
BibTeX
@article{Shi2024,
author = {Shi, Xiaoting and Wallach, Joshua D and Ma, Xiaomei and Rogne, Tormod},
title = {Autoimmune Diseases and Risk of Non‐Hodgkin Lymphoma: A Mendelian Randomisation Study},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70327}
}
EUVIMED